ADAMTS13 and thrombotic thrombocytopenic purpura: Studies have shown that recombinant ADAMTS-13 (rh ADAMTS-13) can be used for the treatment of patients with thrombotic thrombocytopenic purpura, reducing AKI in patients [7,8].